Synergistic Effect of Network-Based Multicomponent Drugs: An Investigation on the Treatment of Non-Small-Cell Lung Cancer with Compound Liuju Formula

Abstract EN

Lung cancer is the most common cause of cancer death with high morbidity and mortality, which non-small-cell lung cancer (NSCLC) accounting for the majority.

Traditional Chinese Medicine (TCM) is effective in the treatment of complex diseases, especially cancer.

However, TCM is still in the conceptual stage.

The interaction between different components remains unknown due to its multicomponent and multitarget characteristics.

In this study, compound Liuju formula was taken as an example to isolate compounds with synergistic biological activity through systems pharmacology strategy.

Through pharmacokinetic evaluation, 37 potentially active compounds were screened out.

Meanwhile, 116 targets of these compounds were obtained by combing with the target prediction model.

Through network analysis, we found that multicomponent drugs can present a synergistic effect through regulating inflammatory signaling pathway, invasion pathway, proliferation, and apoptosis pathway.

Finally, it was confirmed that the bioactive compounds of compound Liuju formula have not only a killing effect on NSCLC tumor cells but also a synergistic effect on inhibiting the secretion of correlative inflammatory mediators, including TNF-α and IL-1β.

The systems pharmacology method was applied in this study, which provides a new direction for analyzing the mechanism of TCM.